Last News
Product news
SEQENS to launch bio-identical hexapeptide-9 for sustainable anti-aging formulations
Apr 07 2026
SEQENS is set to launch PeptiCode™ HP-9, claimed by the company to be one of the first European biotech Hexapeptide-9, developed through the PeptiCode™ biotechnology platform based in Nîmes, France.
